Report overview
This report contains market size and forecasts of Pediatric ADHD Drugs in Global, including the following market information:
Global Pediatric ADHD Drugs Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global Pediatric ADHD Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Tablets Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Pediatric ADHD Drugs include Pfizer, Johnson & Johnson, Eli Lilly and Company, Tris Pharma, Noven Pharmaceuticals, Alcobra Pharmaceuticals, Novartis, GlaxoSmithKline and Purdue Pharma, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pediatric ADHD Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pediatric ADHD Drugs Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global Pediatric ADHD Drugs Market Segment Percentages, by Type, 2022 (%)
Tablets
Oral Liquid
Other
Global Pediatric ADHD Drugs Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global Pediatric ADHD Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital
Retail Pharmacy
Other
Global Pediatric ADHD Drugs Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Pediatric ADHD Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pediatric ADHD Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Pediatric ADHD Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Johnson & Johnson
Eli Lilly and Company
Tris Pharma
Noven Pharmaceuticals
Alcobra Pharmaceuticals
Novartis
GlaxoSmithKline
Purdue Pharma
Takeda Pharmaceutical
Curemark
Supernus Pharmaceuticals
